CJC-1295 (Without DAC)+IP-10mg

Description

CJC-1295 (Without DAC) 5mg + Ipamorelin 5mg (10mg Total) (also known as Modified GRF 1-29 / Ipamorelin blend) is a high-purity, research-grade synthetic dual-peptide formulation engineered to investigate the complementary neuroendocrine pathways of endogenous growth hormone (GH) stimulation and pituitary receptor kinetics in preclinical and in vitro research models.

This dual-mechanism blend co-formulates two selective peptide secretagogues:

• CJC-1295 Without DAC (Modified GRF 1-29, 5mg): A 29-amino acid synthetic analogue of endogenous growth hormone-releasing hormone (GHRH) with specific D-amino acid substitutions that enhance enzymatic resistance against dipeptidyl peptidase-4 (DPP-4). It selectively binds to anterior pituitary GHRH receptors, activating the adenylate cyclase/cAMP pathway to trigger physiologic, pulsatile GH release.
• Ipamorelin (5mg): A selective pentapeptide growth hormone secretagogue receptor (GHSR-1a) agonist (ghrelin mimetic). It stimulates GH release via intracellular calcium mobilization pathways without significantly affecting baseline adrenocorticotropic hormone (ACTH), cortisol, prolactin, or appetite-stimulating cascades.

The co-formulation provides an advanced experimental platform for evaluating dual-receptor somatotropic synergy, downstream insulin-like growth factor 1 (IGF-1) gene expression, cellular regeneration kinetics, and nitrogen retention dynamics while preserving endogenous negative feedback mechanisms.

Product Specifications:

• Quantity: 10mg total per vial (5mg CJC-1295 Without DAC + 5mg Ipamorelin)
• Purity: Research-grade, verified via laboratory testing
• Form: Lyophilised peptide blend
• Storage: Store in a cool, dry environment away from direct light

Intended Use:

This product is intended exclusively for laboratory, academic, and controlled research purposes involving GHRH and GHSR-1a dual-receptor kinetics, pulsatile somatotropic signaling, and cellular regenerative pathway investigations.

Disclaimer:

All information provided is for scientific, educational, and reference purposes only. This product has not been evaluated or approved by any regulatory authority. It is not intended to diagnose, treat, cure, or prevent any disease, and must not be used for human or animal consumption. The purchaser assumes full responsibility for proper handling, storage, and lawful use in a research setting.

Terms of Sale:

By purchasing CJC-1295 (Without DAC) 5mg + Ipamorelin 5mg (10mg Total) from TRUEBASE PEPTIDES, you confirm that you are a qualified professional, researcher, or institution with the expertise required to safely handle and study research compounds. TRUEBASE PEPTIDES shall not be held liable for misuse, improper handling, or any consequences arising from unauthorised application of this compound.